Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS2, and/or s-HBsAg regions of the HBV envelope protein

Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS2, and/or s-HBsAg regions of the HBV envelope protein

US Patent 11389532 · Granted Jul 19, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen2025
Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen2025
Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen2025
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2025
Compositions and methods for antigen targeting to CD1802025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Methods and compositions for activation of innate immune responses through RIG-I2024
Compositions and methods for antigen targeting to CD1802024
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen2024